Immuneering to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today announced that management will present at the Piper Sandler 36 th Annual Healthcare Conference,